TY  - CONF
AU  - Ortiz-Marquez, F.
AU  - Padilla-Leiva, C.
AU  - Cabezudo-Garcia, P.
AU  - Diaz-Cordobes, G.
AU  - Munoz-Becerra, L.
AU  - Mena-Vazquez, N.
PY  - 2022
DO  - 10.1136/annrheumdis-2022-eular.2159
SN  - 0003-4967
UR  - http://hdl.handle.net/10668/20084
T2  - Annals of the rheumatic diseases
AB  - Background: Juvenile idiopathic arthritis (JIA) is a chronic disease requiring years of therapy with non-steroidal anti-inflammatory drugs (NSAIDs), immunosuppressant’s, cytostatics, immunobiological agents. The aforementioned drugs, namely NSAIDs and...
LA  - en
PB  - BMJ Group
KW  - Methotrexate
KW  - Arthritis, Juvenile
KW  - Immunosuppressive Agents
KW  - Cytostatic Agents
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - Cystatin C
KW  - Antibodies
KW  - Kidney Diseases
KW  - Chronic Disease
KW  - Immunoenzym
TI  - Prospective evaluation of cognitive function in patients with juvenile idiopathic arthritis
TY  - conference output
VL  - 81
ER  -